Inoxgen

Nitric oxide, the active ingredient in Inoxgen, is a medical gas presented as a medical gas for endotracheopulmonary inhalation use. It is employed to treat pulmonary hypertension and related respiratory disorders in neonates and adults.

GNH USA supplies Inoxgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to EU quality standards and offers reliable logistics for global distribution. Our network enables timely delivery to critical care units.

Inoxgen is used in the management of pulmonary vascular disorders and acute respiratory conditions. - Neonatal pulmonary hypertension: reduces pulmonary arterial pressure and improves oxygenation in newborns. - Acute respiratory distress syndrome: provides selective pulmonary vasodilation to enhance gas exchange. - Pulmonary hypertension: lowers pulmonary vascular resistance and supports right‑ventricular function in adults. - Persistent pulmonary hypertension of the newborn: stabilizes hemodynamics and facilitates transition to extra‑uterine life.

Inhaled nitric oxide may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: warm sensation of the skin. - Transient hypotension: brief drop in blood pressure.

Serious or Rare Side Effects: - Methemoglobinemia: elevated methemoglobin levels causing cyanosis. - Severe systemic hypotension. - Rebound pulmonary hypertension after abrupt discontinuation.

When using Inoxgen, clinicians should observe specific safety measures to minimize risks. - Monitor blood pressure: watch for sudden drops during administration. - Measure methemoglobin levels: perform regular checks to detect methemoglobinemia. - Use caution in patients with anemia or hemoglobinopathies: increased risk of methemoglobin formation. - Avoid abrupt discontinuation: taper the gas to prevent rebound pulmonary hypertension. - Adjust dose in severe hypoxemia: ensure adequate oxygenation before and during therapy. - Store at ambient temperature: keep cylinders upright, protect from heat and direct sunlight.

Inoxgen can interact with other agents that affect vascular tone or hemoglobin metabolism.

Major Interactions (Avoid): - Systemic vasodilators (e.g., nitroglycerin, hydralazine): may cause profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): can amplify pulmonary vasodilation and hypotension. - Methylene blue: antagonizes nitric oxide’s effect and may precipitate methemoglobinemia.

Moderate Interactions (Monitor Closely): - Inhaled anesthetics (e.g., nitrous oxide): additive vasodilatory effects require blood pressure monitoring. - High concentrations of supplemental oxygen: may reduce nitric oxide efficacy and increase oxidative stress.